Don't think your the only one doggy. After the website update yesterday I fully expected an RNS explaining it as it seemed like it was news that could influence the SP. I give up guessing now ha. Its only the start of the day though so hopefully the RNS machine just has a paper jam (however unlikely).
"Unprovoked attack"???? Did you not read his post? He's always come across as a condescending prat to me and I have never found much of what he posts that useful. He should setup an only fans page he would make a mint off some of you :-)
I'll wait for the RNS thanks not some random geezer on the Internet.
I disagree Beinthelead I can assure you more and more people are interested in the b0ll0cks surrounding Innova its not just people in this share. My brother who cant invest in decent size pants never mind a biotech was telling me about it today without any prompt from me.
There is a lot of irrelevant $hite posted here, why should people be quiet about this issue and move on as on this occasion the issue is directly related to Avacta (at least more so than a lot of topics here).
RE: This sums everything up about HMG?21 Jul 2021 15:50
I emailed my MP as many other have done this lunchtime. She seriously tows the party line in all her voting records so figured I would get nothing but the standard response that other members have received. As I am a bit of a twat as a P.S on the email I added.
"To save you some time so you can go back to counting the numbers of notes in the envelope I have pasted your reply to me below. Please feel to just paste it into your reply, saves you having to ask Boris what you should say"
and added the generic reply everyone seems to get.
RE: Soros and Gates back buyout of UK diagnostic technology group19 Jul 2021 08:50
While I see it as a good thing for Avacta (as per previous RNS on collaborations etc) I am going to have to do the unthinkable and agree somewhat with Turtle. I just don't see any kind of buyout of Avacta resulting from this and I just cant see AS giving up affimers (Gates/soros seem interested in diagnostics and Avactas diagnostic division is nothing without affimers). AS priority has always seemed to be therapeutics to me so I just don't see it and to be honest I am not sure I would want one at the minute.
Can only be good news for Avacta going forward though IF we can get everything powered by affimers. Another iron in the fire that makes £1.40 look dirt cheap.
There is a product on the market you daft melt. If your gonna deramp try something with facts. Also he sold at £1.80 the share price has hit £2.80 since then so bringing up the house sales just enforces the fact that you are a twat.